help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0244
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pörksen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pörksen, S.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Diabetes and Insulin
Right arrow Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 8 2910-2916
Copyright © 2007 by The Endocrine Society

Meal-Stimulated Glucagon Release Is Associated with Postprandial Blood Glucose Level and Does Not Interfere with Glycemic Control in Children and Adolescents with New-Onset Type 1 Diabetes

Sven Pörksen, Lotte B. Nielsen, Anne Kaas, Mirjana Kocova, Francesco Chiarelli, Cathrine Ørskov, Jens J. Holst, Kenneth B. Ploug, Philip Hougaard, Lars Hansen, Henrik B. Mortensen the Hvidøre Study Group on Childhood Diabetes

Pediatric Department (S.P., L.B.N., A.K., H.B.M.) and Department of Neurology (K.B.P.), Glostrup University Hospital, DK-2600 Glostrup, Denmark; Pediatric Clinic (M.K.), Department of Endocrinology and Genetics, 91000 Skopje, Republic of Macedonia; Clinica Pediatrica (F.C.), Ospedale Policlinico, 66013 Chieti, Italy; Medical Anatomy (C.Ø.) and Medical Physiology (J.J.H.), The Panum Institute, DK-2200 Copenhagen, Denmark; Statistics (P.H.), University of Southern Denmark, DK-5230 Odense, Denmark; and Development Projects (S.P., L.H.), Novo Nordisk A/S, DK-2880 Bagsværd, Denmark

Address all correspondence and requests for reprints to: Sven Pörksen, Department of Pediatrics, Forskerparken, Glostrup University Hospital, DK-2600 Glostrup, Denmark. E-mail: svepor01{at}glo.regionh.dk.

Context: The role of glucagon in hyperglycemia in type 1 diabetes is unresolved, and in vitro studies suggest that increasing blood glucose might stimulate glucagon secretion.

Objective: Our objective was to investigate the relationship between postprandial glucose and glucagon level during the first 12 months after diagnosis of childhood type 1 diabetes.

Design: We conducted a prospective, noninterventional, 12-month follow-up study conducted in 22 centers in 18 countries.

Patients: Patients included 257 children and adolescents less than 16 yr old with newly diagnosed type 1 diabetes; 204 completed the 12-month follow-up.

Setting: The study was conduced at pediatric outpatient clinics.

Main Outcome Measures: We assessed residual ß-cell function (C-peptide), glycosylated hemoglobin (HbA1c), blood glucose, glucagon, and glucagon-like peptide-1 (GLP-1) release in response to a 90-min meal stimulation (Boost) at 1, 6, and 12 months after diagnosis.

Results: Compound symmetric repeated-measurements models including all three visits showed that postprandial glucagon increased by 17% during follow-up (P = 0.001). Glucagon levels were highly associated with postprandial blood glucose levels because a 10 mmol/liter increase in blood glucose corresponded to a 20% increase in glucagon release (P = 0.0003). Glucagon levels were also associated with GLP-1 release because a 10% increase in GLP-1 corresponded to a 2% increase in glucagon release (P = 0.0003). Glucagon levels were not associated (coefficient –0.21, P = 0.07) with HbA1c, adjusted for insulin dose. Immunohistochemical staining confirmed the presence of Kir6.2/SUR1 in human {alpha}-cells.

Conclusion: Our study supports the recent in vitro data showing a stimulation of glucagon secretion by high glucose levels. Postprandial glucagon levels were not associated with HbA1c, adjusted for insulin dose, during the first year after onset of childhood type 1 diabetes.




This article has been cited by other articles:


Home page
Diabetes CareHome page
R. J. Brown, N. Sinaii, and K. I. Rother
Too Much Glucagon, Too Little Insulin: Time course of pancreatic islet dysfunction in new-onset type 1 diabetes
Diabetes Care, July 1, 2008; 31(7): 1403 - 1404.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Bollyky and C. J. Greenbaum
The Role of Glucagon in Postprandial Hyperglycemia The Jury's Still Out
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2879 - 2881.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society